[go: up one dir, main page]

ATE233083T1 - Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen - Google Patents

Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen

Info

Publication number
ATE233083T1
ATE233083T1 AT94928700T AT94928700T ATE233083T1 AT E233083 T1 ATE233083 T1 AT E233083T1 AT 94928700 T AT94928700 T AT 94928700T AT 94928700 T AT94928700 T AT 94928700T AT E233083 T1 ATE233083 T1 AT E233083T1
Authority
AT
Austria
Prior art keywords
applications
composition
well
viscoelastic material
physiological
Prior art date
Application number
AT94928700T
Other languages
English (en)
Inventor
Bradford C Webb
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE233083T1 publication Critical patent/ATE233083T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
AT94928700T 1993-04-30 1994-04-06 Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen ATE233083T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5582293A 1993-04-30 1993-04-30
PCT/US1994/003749 WO1994025004A1 (en) 1993-04-30 1994-04-06 Synthetic viscoelastic material for ophthalmic applications

Publications (1)

Publication Number Publication Date
ATE233083T1 true ATE233083T1 (de) 2003-03-15

Family

ID=22000374

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928700T ATE233083T1 (de) 1993-04-30 1994-04-06 Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen

Country Status (13)

Country Link
US (2) US5422376A (de)
EP (1) EP0732913B1 (de)
JP (1) JP2976350B2 (de)
KR (1) KR100246016B1 (de)
AT (1) ATE233083T1 (de)
AU (1) AU681146B2 (de)
CA (1) CA2161774C (de)
DE (1) DE69432188T2 (de)
DK (1) DK0732913T3 (de)
ES (1) ES2192560T3 (de)
HK (1) HK1019005A1 (de)
RU (1) RU2145882C1 (de)
WO (1) WO1994025004A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931165A (en) * 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
US5791352A (en) * 1996-06-19 1998-08-11 Fusion Medical Technologies, Inc. Methods and compositions for inhibiting tissue adhesion
BR0109162A (pt) 2000-03-14 2005-01-11 Alcon Inc Viscoelásticos para uso na cirurgia do ouvido médio
US20030086899A1 (en) * 2000-03-14 2003-05-08 Jafari Masoud R. Chondroitin sulfate containing viscoelastics for use in treating joints
WO2002022139A1 (en) * 2000-09-14 2002-03-21 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
KR20040011426A (ko) * 2000-11-06 2004-02-05 알콘, 인코퍼레이티드 수술용 비흡출 전이성 점탄물
US6756363B1 (en) 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
CA2431367C (en) * 2000-12-20 2010-02-09 Alcon, Inc. Solution for removing cataracts via liquefracture
WO2003011257A1 (en) * 2001-08-01 2003-02-13 Jasjit Singh Composition and process the manufacture of soluble containers with improved gel-strength
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20040101561A1 (en) * 2002-11-13 2004-05-27 Jafari Masoud R. Combinations of viscoelastics for use during surgery
US20120283232A9 (en) * 2003-11-12 2012-11-08 Zhengjun Wang Process for making a pharmaceutical composition
US20050215515A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo Viscoelastic composition, method of use and package
US20060159651A1 (en) * 2005-01-14 2006-07-20 Michael Colvard Gradient molecular weight viscoelastic solutions
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
DE102009037514A1 (de) 2009-08-17 2011-03-10 Dirk-Henning Dr. Menz Wasserlösliche Polysaccharidether und ihre Verwendung
US8845624B2 (en) * 2010-06-25 2014-09-30 Alcon LexSx, Inc. Adaptive patient interface
JP2016501931A (ja) 2012-11-21 2016-01-21 ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション，インコーポレーテッドＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｌｏｕｉｓｖｉｌｌｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ，Ｉｎｃ． 酸化的損傷を減じるための組成物および方法
EP2934484A1 (de) * 2012-12-19 2015-10-28 Kashiv Pharma, LLC Übersättigte stabilisierte nanopartikel für schwerlösliche arzneistoffe
DE102014103512A1 (de) 2014-03-14 2015-09-17 Carl Zeiss Meditec Ag Injektor zur Injektion eines Operations-Hilfsfluids in ein Auge sowie Verfahren zum Erzeugen eines Operations-Hilfsfluids
WO2016130478A1 (en) 2015-02-09 2016-08-18 University Of Louisville Research Foundation, Inc. Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
WO2022172089A1 (en) * 2021-02-12 2022-08-18 I Optima Ltd. Compound, method and system for ophthalmic surgery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
JPH0657245B2 (ja) * 1986-05-14 1994-08-03 ト−メ−産業株式会社 眼科手術用粘弾性溶液
US4819617A (en) * 1986-09-04 1989-04-11 University Of Florida Viscoelastic material for ophthalmic surgery
CA1317226C (en) * 1987-05-04 1993-05-04 Phillip E. Pennell Viscoelastic fluid for ophthalmic surgery and method of using same
US4853374A (en) * 1987-06-09 1989-08-01 M.D.R. Group, Inc. Viscoelastic vitreous substitute with UV blocker
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5218107A (en) * 1991-12-30 1993-06-08 The Dow Chemical Company Removal of undesirable material from water-soluble cellulose ether aqueous solutions

Also Published As

Publication number Publication date
KR100246016B1 (ko) 2000-04-01
USRE42243E1 (en) 2011-03-22
JP2976350B2 (ja) 1999-11-10
ES2192560T3 (es) 2003-10-16
DE69432188D1 (de) 2003-04-03
CA2161774A1 (en) 1994-11-10
US5422376A (en) 1995-06-06
WO1994025004A1 (en) 1994-11-10
CA2161774C (en) 2000-01-04
DE69432188T2 (de) 2004-01-22
RU2145882C1 (ru) 2000-02-27
AU6700894A (en) 1994-11-21
EP0732913B1 (de) 2003-02-26
DK0732913T3 (da) 2003-06-16
AU681146B2 (en) 1997-08-21
JPH09507469A (ja) 1997-07-29
HK1019005A1 (en) 2000-01-14
EP0732913A1 (de) 1996-09-25

Similar Documents

Publication Publication Date Title
ATE233083T1 (de) Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen
US4303676A (en) Hyaluronate based compositions and cosmetic formulations containing same
CA1240929A (en) Chondroitin sulfate/sodium hyaluronate compositions
IT1283911B1 (it) Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
DE69023163D1 (de) Natriumhyaluronat-Zusammensetzung.
ES2148504T3 (es) Acido hialuronico sulfatado en el que el numero de grupos sulfato por unidad repetitiva varia entre 0,5 y menos de 2.
EP0167363A2 (de) Vernetzte Glykosaminoglykane und ihre Verwendung
DE69522550D1 (de) Flüssiges ophthalmologisches abgabesystem mit verzögerter freisetzung
DK54390D0 (da) Okularcyklosporinpraeparat
BR9714270A (pt) Composição lìquida de limpeza de pele
SE8900586D0 (sv) Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
NZ226171A (en) Gel formulation containing polypeptide growth factor
US6051560A (en) Chrondroitin sulfate/sodium hyaluronate composition
BRPI0106913B8 (pt) composições transparentes de limpeza em barra que são eficazes e não são irritantes para os olhos
BR9401241A (pt) Composição aquosa para tratamento de feridas e processo para formar a mesma
SE9401540D0 (sv) Munhygienkomposition
JPS6084225A (ja) 点眼剤
ES2063440T3 (es) Utilizacion de polisacaridos en preparaciones para el tratamiento de heridas.
BR0115154A (pt) material viscoelástico transicional não-aspirante para uso em cirurgia
JPH1143446A (ja) 水性製剤の増粘剤
BR0012573A (pt) Combinações de substâncias ativas fungicidas
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
KR890001589A (ko) 올리고당 또는 다당류를 함유하는 약학 조성물
RU93015155A (ru) Лекарственное средство для лечения дистрофических заболеваний и травм глазных тканей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties